Cellectar Biosciences, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Cellectar Biosciences, Inc. (CLRB) had Common Stock, Capital Shares Reserved for Future Issuance of 1.68 million shares as of 2019-06-13, per its 10-K filed 2021-03-02.
Discontinued › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2021-03-02
- 2019-06-13: Common Stock, Capital Shares Reserved for Future Issuance 1.68M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 982.00K shares.
- 2018-05-31: Common Stock, Capital Shares Reserved for Future Issuance 282.00K shares.
- 2012-12-31: Common Stock, Capital Shares Reserved for Future Issuance 10.00M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2019-06-13 | 1.68M shares 10-K · filed 2021-03-02 | 982.00K shares 10-K · filed 2020-03-09 |
| 2018-05-31 | 282.00K shares 10-K · filed 2019-02-26 | |
| 2012-12-31 | 10.00M shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |